Protagonist Therapeutics Names William A. Hodder as Senior Vice President, Corporate Development
Protagonist Therapeutics Closes 2nd Tranche of $18 Million Series B for Advancing Development Candidate to Clinical Trials in 2015
Protagonist Therapeutics Elects Chaitan Khosla, Ph.D. to Board of Directors
July 14-18, 2015
December 10-12, 2015
Protagonist Therapeutics Inc.
521 Cottonwood Drive, Suite 100
Milpitas, CA 95035-7404 USA